This inventor holds 1 USPTO granted patent. Top assignee: The University of Hong Kong. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Lakshman Perera Samaranayake: Innovator in Antifungal Compounds
Introduction
Lakshman Perera Samaranayake is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of antifungal treatments through his innovative research and development. His work focuses on creating effective solutions for fungal infections, which are a growing concern in medical science.
Latest Patents
Lakshman holds a patent for an antifungal compound and its uses. The patent describes a novel antifungal compound that is effective in treating fungal infections. Specifically, the compound is a small molecule that inhibits the transition of yeast to hypha under robust hyphal inducing conditions at lower concentrations. The patent also discloses a composition that includes the antifungal compound, which can be formulated as a pharmaceutical composition. Furthermore, the compound exhibits antifungal activity against a wide range of fungal species and serves as an anti-biofilm agent against fungal infections. He has 1 patent to his name.
Career Highlights
Lakshman is affiliated with The University of Hong Kong, where he continues to advance his research in antifungal compounds. His work is crucial in developing new treatments that can combat fungal infections effectively.
Collaborations
Some of his notable coworkers include Chaminda Jayampath Seneviratne and Yi Tsun Richard Kao. Their collaborative efforts contribute to the ongoing research and development in the field of antifungal treatments.
Conclusion
Lakshman Perera Samaranayake is a pioneering inventor whose work in antifungal compounds is making a significant impact in medical science. His innovative approaches to treating fungal infections highlight the importance of research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
